Terminal deletion of chromosome 13 in a fetus with normal NIPT: The added value of invasive prenatal diagnosis in the NIPT era

In the age of noninvasive prenatal testing, there is still an important role for invasive prenatal diagnosis, even for chromosomes 13, 18, and 21.

[1]  K. Yan,et al.  Pilot study of a novel multi‐functional noninvasive prenatal test on fetus aneuploidy, copy number variation, and single‐gene disorder screening , 2019, Molecular genetics & genomic medicine.

[2]  F. Grati,et al.  Noninvasive screening by cell‐free DNA for 22q11.2 deletion: Benefits, limitations, and challenges , 2019, Prenatal diagnosis.

[3]  F. Grati,et al.  Genome‐wide non‐invasive prenatal screening for all cytogenetically visible imbalances , 2018, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[4]  H. Peeters,et al.  Predicting fetoplacental chromosomal mosaicism during non‐invasive prenatal testing , 2018, Prenatal diagnosis.

[5]  D. Oepkes,et al.  Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: results of the TRIDENT study , 2017, Genetics in Medicine.

[6]  M. Plana,et al.  Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysis , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[7]  Amin R. Mazloom,et al.  Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases , 2017, Genetics in Medicine.

[8]  B. Faas,et al.  Clinical utility of non‐invasive prenatal testing in pregnancies with ultrasound anomalies , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[9]  Zhi-bin Niu,et al.  Chromosome 13q deletion syndrome involving 13q31-qter: A case report , 2017, Molecular medicine reports.

[10]  D. Grosu,et al.  Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. , 2016, American journal of obstetrics and gynecology.

[11]  D. Grosu,et al.  Clinical Validation of a Non-Invasive Prenatal Test for Genome-Wide Detection of Fetal Copy Number Variants , 2015, bioRxiv.

[12]  P. Klaritsch,et al.  Cell-Free DNA Testing for Fetal Chromosomal Anomalies in clinical practice: Austrian-German-Swiss Recommendations for non-invasive prenatal tests (NIPT) , 2015, Ultraschall in der Medizin.

[13]  John Tynan,et al.  Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts , 2015, Prenatal diagnosis.

[14]  H. Peeters,et al.  Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management , 2015, European Journal of Human Genetics.

[15]  A. Oliphant,et al.  Gestational age and maternal weight effects on fetal cell‐free DNA in maternal plasma , 2013, Prenatal diagnosis.

[16]  I. Janssen,et al.  Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells , 2012, Expert opinion on biological therapy.

[17]  Geert Vandeweyer,et al.  CNV-WebStore: Online CNV Analysis, Storage and Interpretation , 2011, BMC Bioinformatics.

[18]  S. Gimelli,et al.  13q Deletion and central nervous system anomalies: further insights from karyotype–phenotype analyses of 14 patients , 2006, Journal of Medical Genetics.

[19]  D. Warburton,et al.  Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired , 1998, Nature Genetics.

[20]  E. Grace,et al.  The 13q- deletion syndrome. , 1971, Journal of medical genetics.